A film-coated lozenge intended to dissolve in the oral cavity comprising: - a core comprising at least one active ingredient and at least one cooked sugar, and - a shell, characterised in that the shell consists successively of an inner insulating layer comprising at least one film forming polymer, a layer comprising at least one active ingredient and an outer insulating layer comprising at least one film forming polymer, and wherein the core and the layer of the shell comprising at least one active ingredient comprise respectively a single active ingredient, the active ingredient being respectively nicotine resinate in the core and nicotine bitartrate in the layer of the shell comprising an active ingredient, further characterised in that: the lozenge further comprises an outer layer coating the shell comprising a film forming polymer, the dissolution time of the outer layer coating the shell and of the shell, as measured by a dissolution test in a physiological pH buffer as described in the description in example 3, is between 5 seconds and 5 minutes the total dissolution time of the film-coated lozenge is between 15 and 40 minutes, measured by a dissolution test in a physiological pH buffer as described in the description in example 3, and the film forming polymer is copovidone. - a core comprising at least one active ingredient and at least one cooked sugar, and - a shell, characterised in that the shell consists successively of an inner insulating layer comprising at least one film forming polymer, a layer comprising at least one active ingredient and an outer insulating layer comprising at least one film forming polymer, and wherein the core and the layer of the shell comprising at least one active ingredient comprise respectively a single active ingredient, the active ingredient being respectively nicotine resinate in the core and nicotine bitartrate in the layer of the shell comprising an active ingredient, further characterised in that: the lozenge further comprises an outer layer coating the shell comprising a film forming polymer, the dissolution time of the outer layer coating the shell and of the shell, as measured by a dissolution test in a physiological pH buffer as described in the description in example 3, is between 5 seconds and 5 minutes the total dissolution time of the film-coated lozenge is between 15 and 40 minutes, measured by a dissolution test in a physiological pH buffer as described in the description in example 3, and the film forming polymer is copovidone. characterised in that the shell consists successively of an inner insulating layer comprising at least one film forming polymer, a layer comprising at least one active ingredient and an outer insulating layer comprising at least one film forming polymer, and wherein the core and the layer of the shell comprising at least one active ingredient comprise respectively a single active ingredient, the active ingredient being respectively nicotine resinate in the core and nicotine bitartrate in the layer of the shell comprising an active ingredient, further characterised in that: the lozenge further comprises an outer layer coating the shell comprising a film forming polymer, the dissolution time of the outer layer coating the shell and of the shell, as measured by a dissolution test in a physiological pH buffer as described in the description in example 3, is between 5 seconds and 5 minutes the total dissolution time of the film-coated lozenge is between 15 and 40 minutes, measured by a dissolution test in a physiological pH buffer as described in the description in example 3, and the film forming polymer is copovidone. the lozenge further comprises an outer layer coating the shell comprising a film forming polymer, the dissolution time of the outer layer coating the shell and of the shell, as measured by a dissolution test in a physiological pH buffer as described in the description in example 3, is between 5 seconds and 5 minutes the total dissolution time of the film-coated lozenge is between 15 and 40 minutes, measured by a dissolution test in a physiological pH buffer as described in the description in example 3, and the film forming polymer is copovidone.